Shaily Engineering Plastics Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 27, 2025

Shaily Engineering Plastics held its 45th AGM on September 27, 2025 via video conferencing, with all 10 ordinary and special business resolutions approved. The company reported strong FY25 results: revenue of Rs. 787 crores (up 22% YoY), EBITDA of Rs. 178 crores (up 45% YoY) with margins expanding 350 basis points to 22.7%, and PAT of approximately Rs. 93 crores (up 63% YoY). The healthcare segment grew 53% YoY, driven by seven patented pen-based platforms for GLP-1 weight-loss drug delivery devices, and now forms about 21% of revenue, expected to rise to 25-30% in two years. The company announced a Rs. 150 crore investment to expand pen manufacturing capacity by 40-50 million units by December 2026, and recently set up a Dubai subsidiary (Shaily Innovations FZCO). ROCE stood at 24.4%, ROE at 18.5%, and total debt at around Rs. 218 crores, with capacity utilization targeted to rise from 50% to 80% by end of FY27.